Abstract:During the past four decades, a substantial progress has been made in the field of hematopoietic stem cell transplantation (HSCT). From July, 2007 to December, 2010, a transplant survey from 42 HSCT units indicates that the types of transplantation performed are related identical (43%), related mismatched/haploidentical (28%), unrelated donor matched (11%), unrelated donor mismatched (7%), umbilical cord blood (UCB, 2%) and autologous (9%). The distribution of disease entities being transplanted in allogeneic settings is acute myeloid leukemia (AML) (34%), acute lymphoblastic leukemia(ALL) (24%), chronic myeloid leukemia (CML) (20%), myelodysplastic syndrome (MDS) (8%), aplastic anemia (AA) (7%), Mediterranean anemia (MIA) (2%), non-Hodgkin's lymphoma (NHL) (3%), and other diseases (3%). Clinical data from Peking University Institute of Hematology and other transplant centers suggest that haploidentical transplantation has been a choice of the best alternative source of stem cells for individual patients without matched sibling donors. A modified donor lymphocyte infusion (DLI) approach can be safely used for prophylaxis and treatment of leukemia relapse in patients with advanced leukemia following mismatched transplant. The number of transplants from unrelated donor or related mismatched/haploidentical donor has increased significantly during recent years. Double UCBT is a promising strategy for the therapy of hematological disease. In addition, mesenchymal stem cell (MSC) transplantation may be a potential therapeutic approach for treating systemic lupus erythematosus (SLE).

Hematopoietic Stem Cells Derived fom Embryonic Stem Cells in Vitro

[Progress in the Derivation, Culture of Human Embryonic Stem Cells].

Human Amniotic Epithelial Stem Cells: A Promising Seed Cell for Clinical Applications

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Specific Blood Cells Derived From Pluripotent Stem Cells: An Emerging Field With Great Potential In Clinical Cell Therapy

In VitroandIn VivoHepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

Progress and Challenges in Generating Functional Hematopoietic Stem/progenitor Cells from Human Pluripotent Stem Cells.

The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells

[Research progress of haematopoietic stem cells to generate immune cells and its application]

The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use

Analysis on expansion potentials and pre-clinical safeties of hematopoietic stem cells from human umbilical cord blood.

Hematopoietic stem cell transplantation for the treatment of hematological diseases

Generation of Hematopoietic Stem Cells from Purified Embryonic Endothelial Cells by A Simple and Efficient Strategy

Recent advances in tissue stem cells

Hematopoietic stem cell transplantation:everyone has a donor

In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

Hematopoietic stem cells characteristics: from isolation to transplantation.

Hematopoietic Stem Cell Transplantation in China: Current Status and Prospects.

Establish the Hematopoietic Stem Cell Transplantation System with Chinese Characteristics

[Research Advances on Directional Induction and Differentiation in Vitro from Human Pluripotent Stem Cells into Erythrocytes].

Update on Preclinical and Clinical Efforts on Ex-Vivo Expansion of Hematopoietic Stem and Progenitor Cells